Literature DB >> 19172201

Advances in inflammatory bowel disease: are patients taking their medicines? Interview by Paul C. Adams.

Subrata Ghosh.   

Abstract

Dr Subrata Ghosh is the Professor of Gastroenterology at the Imperial College, Hammersmith Hospital, London, England. He has bench-to-bedside research interests in inflammatory bowel disease (IBD) and other intestinal inflammatory diseases. He will become the Head of the Division of Gastroenterology at the University of Calgary, Calgary, Alberta, in March 2009.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172201      PMCID: PMC2695140          DOI: 10.1155/2009/356952

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  4 in total

Review 1.  Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?

Authors:  I D R Arnott; D Watts; S Ghosh
Journal:  Aliment Pharmacol Ther       Date:  2002-05       Impact factor: 8.171

2.  The challenges of medication non-adherence in ulcerative colitis: Practical suggestions to help patients.

Authors:  Subrata Ghosh
Journal:  J Crohns Colitis       Date:  2007-11-26       Impact factor: 9.071

3.  Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey.

Authors:  Subrata Ghosh; Rod Mitchell
Journal:  J Crohns Colitis       Date:  2007-09       Impact factor: 9.071

Review 4.  Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies.

Authors:  A B Hawthorne; G Rubin; S Ghosh
Journal:  Aliment Pharmacol Ther       Date:  2008-03-31       Impact factor: 8.171

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.